Abstract
Colin Sutherland discusses a Policy Forum article that explores the design and standardization of pre-licensure phase III antimalarial treatment trials.
Publication types
-
Comment
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimalarials / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Drug Evaluation
-
Drug Therapy, Combination
-
Humans
-
Malaria, Falciparum / drug therapy*
-
Malaria, Falciparum / parasitology
-
Treatment Outcome